Comparisons of 3-month Versus 6-month Solifenacin Treatment for Female OAB Patients

• Status: Unknown status
• Trial end date: 2015-12-01
• Target enrollment: 0
• Participant gender: Female

Summary

To investigate whether prolonged period of treatment (6 months) can have a better therapeutic outcome than conventional period (3 months) of antimuscarinics.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: National Taiwan University Hospital
• Treatments: Solifenacin Succinate

Criteria

Inclusion Criteria:

• Women who have overactive bladder syndrome

Exclusion Criteria:

• Women who are less than 20 year-old